Long-term follow-up of first generation versus new-generation drug-eluting stents in three-vessel coronary artery disease

These findings indicated that in patients with three-vessel disease, PCI with new-generation DES is associated with a significantly increased event-free survival rate of MACE at 3 years as compared to first-generation DES.